Skip to main content
news
A sign of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. REUTERS/Tingshu Wang

 

Sinopharm Group, an investment consortium led by Sinopharm Group, and China Traditional Chinese Medicine Holdings (China TCM) recently announced a take-private deal for the Hong Kong-listed China TCM through a scheme of arrangement.

The total transaction amount is approximately $2 billion, marking the largest take-private deal announced so far this year.

Haiwen & Partners served as legal counsel to one of the consortium members of the offeror, China State-Owned Enterprise Mixed Ownership Reform Fund, providing legal services in both Mainland China and Hong Kong. Meanwhile, Clifford Chance acted as the legal advisor to CITIC Securities, the financial advisor to the offeror.

The consortium behind the offeror comprises the Mixed Ownership Fund, Sinopharm (Hong Kong), Advanced Manufacturing Industry Investment Fund Phase II, China Reform Development Investment Management, Chongqing Fuling Industry Development Group, and Red Investment Limited.

China TCM primarily engages in the production and sale of traditional Chinese medicine and pharmaceutical products, focusing on Chinese medicine granules, patent medicines, and Chinese medicinal slices. China TCM has been listed in Hong Kong since 1993.

The Haiwen team was led by partners Wu Zuolong and Lin Xixiang, while partner Tommy Tam led the Clifford Chance team.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Deals

Trilegal, CAM advise on $900 mln Brookfield-Gentari deal amid renewable M&A surge

by Nimitt Dixit |

Trilegal and Cyril Amarchand Mangaldas have advised on Brookfield Asset Management's $900 million sale of a 1.6 GW portfolio of solar and wind assets in India to Gentari Renewables India, a Petronas Group company.

Deals

Trilegal, CAM, Khaitan advise on $300 mln EnerGrid green energy platform

by Nimitt Dixit |

Trilegal and Cyril Amarchand Mangaldas have advised Norwegian and British investors on the formation of $300 million green energy platform EnerGrid, in partnership with IndiGrid, the Mumbai-based power transmission infrastructure investment trust backed by KKR.

Deals

Simpson Thacher, and Nishimura guide KKR's $2.55 bln exit from Seiyu

by Nimitt Dixit |

U.S. law firm Simpson Thacher & Bartlett and Japanese Big Four firm Nishimura & Asahi have advised private equity giant KKR on its $2.55 billion exit from Japanese supermarket chain Seiyu through a sale to Trial Holdings.